Logo
SubscribeSign In
LeaderPortfolio
Billionaire Profile
Jin Lei
Global Rank
#2661

Image: Public domain | via Wikimedia Commons

Jin Lei

CEO, GeneScience Pharmaceuticals
CN
Real-Time Net Worth
$1.3B
As of December 2025
Age
60
Source
Pharmaceuticals
Industry
healthcare
Citizenship
CN

Biography

Jin Lei, a prominent figure in the pharmaceutical industry, is the CEO of GeneScience Pharmaceuticals. His estimated net worth is $1.3 billion, primarily stemming from his success in the healthcare sector. Jin Lei's career began after obtaining a Ph.D. from the University of California, followed by a tenure at Genentech. He returned to China in 1995, co-founding GeneScience Pharmaceuticals, a manufacturer of recombinant human growth hormone. His achievements include leading GeneScience through a merger with Changchun High & New Technology Industries Group, propelling the company to public status and significantly impacting the pharmaceutical landscape in China.

Wealth Over Time

In-Depth Profile

Early Life

Information regarding Jin Lei's early life is limited. However, it is known that he holds a Master's degree from the Chinese Academy of Sciences and a Ph.D. from the University of California. After receiving his doctorate, Jin Lei worked for the biomedical firm Genentech in the United States.

Rise to Success

Jin Lei returned to China in 1995 and co-founded GeneScience Pharmaceuticals in 1996. The company was established with funding from Changchun High and New Tech. GeneScience Pharmaceuticals specializes in manufacturing recombinant human growth hormone. In 2019, GeneScience went public by merging with Shenzhen-listed Changchun High & New Technology Industries Group.

Key Business Strategies

Key business strategies include leading GeneScience through a merger with Shenzhen-listed Changchun High & New Technology Industries Group in 2019, which took the company public.

Philanthropy

Specific philanthropy amounts are unavailable from the search results.

Career Milestones

1995

Returned to China

Jin Lei returned to China after working at Genentech in the U.S.

1996

Co-founded GeneScience Pharmaceuticals

Jin Lei co-founded GeneScience Pharmaceuticals with funding from Changchun High and New Tech.

2019

GeneScience went public

GeneScience went public by merging with Shenzhen-listed Changchun High & New Technology Industries Group.

Philanthropy & Social Impact

Unspecified

Unknown

$XB

Philanthropic information not found